Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Faecal haemoglobin concentration predicts all-cause mortality.
Deding U, Kaalby L, Steele R, Al-Najami I, Kobaek-Larsen M, Plantener E, Madsen JB, Madsen JS, Bjørsum-Meyer T, Baatrup G. Deding U, et al. Among authors: steele r. Eur J Cancer. 2023 May;184:21-29. doi: 10.1016/j.ejca.2023.02.009. Epub 2023 Feb 15. Eur J Cancer. 2023. PMID: 36889038 Free article.
Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
Forsberg A, Westerberg M, Metcalfe C, Steele R, Blom J, Engstrand L, Fritzell K, Hellström M, Levin LÅ, Löwbeer C, Pischel A, Strömberg U, Törnberg S, Wengström Y, Ekbom A, Holmberg L, Hultcrantz R; SCREESCO investigators. Forsberg A, et al. Among authors: steele r. Lancet Gastroenterol Hepatol. 2022 Jun;7(6):513-521. doi: 10.1016/S2468-1253(21)00473-8. Epub 2022 Mar 14. Lancet Gastroenterol Hepatol. 2022. PMID: 35298893 Clinical Trial.
What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?
Flander L, Dekker E, Andersen B, Larsen MB, Steele RJ, Malila N, Sarkeala T, van der Vlugt M, de Klerk C, Knottnerus B, Bertels L, Woudstra A, Spaander MCW, Fransen M, Heinavaara S, Dillon M, Ait Ouakrim D, Jenkins M. Flander L, et al. Cancer Control. 2022 Jan-Dec;29:10732748221121383. doi: 10.1177/10732748221121383. Cancer Control. 2022. PMID: 35969473 Free PMC article.
Use of faecal occult blood tests in symptomatic patients.
Steele R, Forgacs I, McCreanor G, Benton S, Machesney M, Rees C, Halloran SP, Abulafi M, Alsina D. Steele R, et al. BMJ. 2015 Aug 11;351:h4256. doi: 10.1136/bmj.h4256. BMJ. 2015. PMID: 26265582 No abstract available.
Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial.
Atkin W, Dadswell E, Wooldrage K, Kralj-Hans I, von Wagner C, Edwards R, Yao G, Kay C, Burling D, Faiz O, Teare J, Lilford RJ, Morton D, Wardle J, Halligan S; SIGGAR investigators. Atkin W, et al. Lancet. 2013 Apr 6;381(9873):1194-202. doi: 10.1016/S0140-6736(12)62186-2. Epub 2013 Feb 14. Lancet. 2013. PMID: 23414650 Free article. Clinical Trial.
1,824 results